Shuangyue Liu

2 clinical trials · Sponsor

Record	Firm	Date
Prospective Multicenter Single-arm Trial: AK112 + Nab-paclitaxel/Carboplatin Neoadjuvant for TNBC (NCT07103447)	Shuangyue Liu	2025-09-10
Study of Dalpiciclib Combined With Letrozole in the Maintenance Treatment of HR Positive and HER2 Negative Metastatic Breast Cancer After First-line Chemotherapy (NCT05979220)	Shuangyue Liu	2023-12-01

Every clearance here is in the API, with alerts when new ones post.